PUBLICATIONS

13.  Tumor Cell Lysate-Loaded Immunostimulatory Spherical Nucleic Acids as Therapeutics for Triple-Negative Breast Cancer

Callmann, C.E., Cole, L.E., Kusmierz, C.D., Huang, Z., Horiuchi, D, and C.A. Mirkin*

 

Proceedings of the National Academy of Sciences 2020

DOI: 10.1073/pnas.2005794117

------

11.  Defining the Design Parameters for In Vivo Enzyme Delivery Through Protein Spherical Nucleic Acids

Kusmierz, C., Bujold, K., Callmann, C.E., and C.A. Mirkin*

 

ACS Central Science 2020, 6, 5, 815–822.

DOI: 10.1021/acscentsci.0c00313.

------

10.  Peptide-Polymer Amphiphiles and Protein-Like Polymers

Callmann, C.E., Thompson, M.P., and N.C. Gianneschi*

Accounts of Chemical Research, 2020, 53, 2, 400.DOI: 10.1021/acs.accounts.9b00518.

------

9.  Sequence Multiplicity within Spherical Nucleic Acids

Huang, Z., Cole, L.E., Callmann, C.E., Wang, S., and C.A. Mirkin*

ACS Nano, 2020, 14, 1, 1084.

DOI: 10.1021/acsnano.9b08750

------

8.  Antitumor Activity of Octadecanedioic Acid-Paclitaxel Complexed with Human Serum Albumin

Callmann, C.E., LeGuyader, C.L., Burton, S., Thompson, M.P., Hennis, R.H., Barback, C.V., Henrickson, N.M., Chan, W.C., Jeremko, M.J., Yang, J., Garcia, A., Burkart, M.D., Gilson, M., Momper, J.D., Bertin, P.A., and N.C. Gianneschi*

Journal of the American Chemical Society, 2019, 141, 11765.

DOI:10.1021/jacs.9b04272

------

7.  Delivery of Immunotherapeutic Nanoparticles to Tumors via Enzyme-Directed Assembly

Battistella, C.†, Callmann, C.E.†, Thompson, M.P., Yao, S., Hayashi, T., Carson, D.A., and N.C. Gianneschi*

Advanced Healthcare Materials, 2019, 1901105.

DOI: 10.1002/adhm.201901105

------

6.  Tumor Retention of Enzyme-Responsive Pt(II) Drug-Loaded Nanoparticles Imaged by NanoSIMS and Fluorescence Microscopy

Proetto, M.P., Callmann, C.E., Cliff, J., Szymanski, C.J., Hu, D., Evans, J.E.; Orr, G., Howell, S.B., and N.C. Gianneschi*

ACS Central Science, 2018, 4, 1477.

DOI: 10.1021/acscentsci.8b00444

------

5.  Micellar Thrombin-Binding Aptamers: Reversible Nanoscale Anticoagulants

Roloff, A., Carlini, A.S., Callmann, C.E., and N.C. Gianneschi*

Journal of the American Chemical Society, 2017, 139, 16442.

DOI: 10.1021/jacs.7b07799

------

4.  Enzyme-Responsive Nanoparticles for the Treatment of Disease

Callmann, C.E. and N.C. Gianneschi*

Methods in Molecular Biology, 2017, 1570, 223.

DOI:10.1007/978-1-4939-6840-4_15

------

3.  Enzyme-Responsive Nanoparticles Release Cargo Upon Exposure to Matrix Metalloproteinase and Reactive Oxygen Species

Daniel, K.B.†, Callmann, C.E.†, Cohen, S.M.*, and N.C. Gianneschi*

Chemical Communications, 2016, 52, 2126.

DOI: 10.1039/c5cc09164k

------

2.  Therapeutic Enzyme-Responsive Nanoparticles for Targeted Delivery and Accumulation in Tumors

Callmann, C.E., Barback, C.V., Thompson, M.P., Hall, D.J., Mattrey, R.F., and N.C. Gianneschi*

Advanced Materials, 2015, 27, 4611.

DOI:10.1002/adma.201501803

------

1.  Stimuli-Responsive Nanomaterials for Biomedical Applications

Blum, A. P., Kammeyer, J. K.†, Rush, A. M.†, Callmann, C. E., Hahn, M. E., and N.C. Gianneschi*

Journal of the American Chemical Society, 2015, 137, 6, 2140. DOI:10.1021/ja510147n

12.  Paclitaxel-Terminated Peptide Brush Polymers

Zhu, J., Sun, H., Callmann, C.E., Thompson, M.P., Battistella, C., Proetto, M.T., Carlini, A.S., and N.C. Gianneschi*

 

Chemical Communications 2020

DOI: 10.1039/C9CC10023G.

------

©2020 by Cassandra Callmann, Ph.D.